Compare BKNG & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKNG | TMO |
|---|---|---|
| Founded | 1997 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.8B | 176.8B |
| IPO Year | 1998 | 1996 |
| Metric | BKNG | TMO |
|---|---|---|
| Price | $175.93 | $487.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 29 | 19 |
| Target Price | ★ $5,883.18 | $639.83 |
| AVG Volume (30 Days) | 286.2K | ★ 1.9M |
| Earning Date | 04-28-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.00% | 0.35% |
| EPS Growth | N/A | ★ 7.32 |
| EPS | ★ 165.57 | 17.74 |
| Revenue | ★ $26,917,000,000.00 | $20,918,000,000.00 |
| Revenue This Year | $13.42 | $6.21 |
| Revenue Next Year | $8.56 | $5.11 |
| P/E Ratio | ★ $25.32 | $27.70 |
| Revenue Growth | 13.39 | ★ 14.47 |
| 52 Week Low | $3,765.45 | $385.46 |
| 52 Week High | $5,837.03 | $643.99 |
| Indicator | BKNG | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 8.92 | 45.54 |
| Support Level | N/A | $453.76 |
| Resistance Level | $5,548.78 | $497.64 |
| Average True Range (ATR) | 125.20 | 13.67 |
| MACD | -256.01 | 4.04 |
| Stochastic Oscillator | 0.22 | 60.21 |
Booking is the world's largest online travel agency by sales, offering booking and payment services for hotel and alternative accommodation rooms, airlines, rental cars, restaurants, cruises, experiences, and other vacation packages. The company operates several branded travel booking sites, including Booking.com, Agoda, OpenTable, Rentalcars.com, Kayak, and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).